Innate Pharma (IPHA) Q2 2021 Earnings Report

157 Followers

IPHA Q2 2021 EPS Results

Actual EPS-$0.35

Consensus EPS-$0.30

Beat/MissMissed by -$0.05

One Year Ago EPS-$0.08

Actual Revenue$11.23M

Expected Revenue$30.63M

Beat/MissMissed by -$19.40M

YoY Revenue Growth-65.83%

QuarterQ2 2021

Date09/15/2021

TimeBefore Open

Conference CallWednesday, September 15, 2021

IPHA Upcoming Earnings

Innate Pharma's next earnings date is estimated for March 25, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 25, 2027	2026 (Q4)	-0.29 / -	-0.358	―
Sep 17, 2026	2026 (Q2)	-0.18 / -0.24	-0.296	18.58% (+0.05)
Mar 26, 2026	2025 (Q4)	-0.14 / -0.36	-0.346	-3.47% (-0.01)
Sep 17, 2025	2025 (Q2)	-0.33 / -0.30	-0.342	13.45% (+0.05)
Mar 27, 2025	2024 (Q4)	-0.27 / -0.35	-0.13	-166.15% (-0.22)
Sep 12, 2024	2024 (Q2)	-0.30 / -0.34	0.021	-1728.57% (-0.36)
Mar 21, 2024	2023 (Q4)	-0.44 / -0.13	-0.88	85.23% (+0.75)
Sep 14, 2023	2023 (Q2)	0.09 / 0.02	0.08	-73.75% (-0.06)
Mar 23, 2023	2022 (Q4)	-0.41 / -0.88	-0.378	-132.80% (-0.50)
Sep 15, 2022	2022 (Q2)	0.38 / 0.08	-0.355	122.54% (+0.43)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed